| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/15/2001 | WO2001018193A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | WO2001018192A2 Synthetic vectors, transgenic plants containing them, and methods for obtaining them |
| 03/15/2001 | WO2001018177A1 Method and system for non-random selection of plant and tissue products |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018175A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 03/15/2001 | WO2001018174A2 Cell growth substrate |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018053A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018050A2 T2r taste receptor family |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018048A2 Smooth muscle cell promoter and uses thereof |
| 03/15/2001 | WO2001018047A1 Dendritic cell membrane protein fire |
| 03/15/2001 | WO2001018043A2 Neurogenic compositions and methods |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018022A1 52 human secreted proteins |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018014A1 29 human cancer associated proteins |
| 03/15/2001 | WO2001017687A2 Methods of modification of selected cells in a magnetic cell separation column |
| 03/15/2001 | WO2001017572A1 Materials for culturing cardiovascular tissues and method of tissute regeneration |
| 03/15/2001 | WO2001017532A1 Human neuropeptide receptor |
| 03/15/2001 | WO2001017514A1 Modulation of gene expression by modulating histone acetylation |
| 03/15/2001 | WO2001017332A1 TRANSGENIC PLANTS CONTAINING dnaK GENE OR hsp70 GENE |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000073440A8 Pollinosis-associated gene 787 |
| 03/15/2001 | WO2000068362A3 Undifferentiated erythroid cells and their use in ligand binding assays |
| 03/15/2001 | WO2000067672A3 Tissue engineering for making tubular implants |
| 03/15/2001 | WO2000066732A3 Laminin 8 and methods for its use |
| 03/15/2001 | WO2000066178A9 Lim mineralization protein splice variants |
| 03/15/2001 | WO2000029603A8 Low cost manufacture of oligosaccharides |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | CA2848454A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2384777A1 T2r taste receptor family |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384658A1 Neurogenic compositions and methods |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384405A1 Dendritic cell membrane protein fire |
| 03/15/2001 | CA2384113A1 Method and system for non-random selection of plant and tissue products |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2383800A1 52 human secreted proteins |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383776A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383767A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 03/15/2001 | CA2383321A1 Smooth muscle cell promoter and uses thereof |
| 03/15/2001 | CA2382729A1 29 human cancer associated proteins |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2349413A1 Clean synthetic vectors, plasmids, transgenic plants and plant parts containing them, and methods for obtaining them |
| 03/15/2001 | CA2349207A1 Opg fusion protein compositions and methods |
| 03/15/2001 | CA2348657A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/14/2001 | EP1083230A1 Viral replicons and viruses dependent on inducing agents |
| 03/14/2001 | EP1083224A2 Apoptin-associating protein |
| 03/14/2001 | EP1083223A1 Novel immortalized hepatic cell line originating in humans |
| 03/14/2001 | EP1082457A2 Nucleic acid encoding rate agouti related protein |
| 03/14/2001 | EP1082444A1 Adeno-associated virus vectors and uses thereof |
| 03/14/2001 | EP1082440A1 LIPOPOLYSACCHARIDE $g(a)-2,3 SIALYLTRANSFERASE OF $i(CAMPYLOBACTER JEJUNI) AND ITS USES |
| 03/14/2001 | EP1082439A2 Recombinant narbonolide polyketide synthase |
| 03/14/2001 | EP1082438A2 Genetic method for producing riboflavin |
| 03/14/2001 | EP1082435A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 03/14/2001 | EP1082434A1 NOVEL INSECTICIDAL TOXINS FROM $i(XENORHABDUS NEMATOPHILUS) AND NUCLEIC ACID SEQUENCES CODING THEREFOR |
| 03/14/2001 | EP1082433A1 Interleukins-21 and 22 |
| 03/14/2001 | EP1082432A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 03/14/2001 | EP1082430A1 Kunitz domain polypeptide and materials and methods for making it |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082424A1 Tumor suppressor |
| 03/14/2001 | EP1082423A1 Cyclin e2 genes and proteins |
| 03/14/2001 | EP1082421A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same |
| 03/14/2001 | EP1082420A2 Human nucleic acid sequences from normal pancreas tissue |
| 03/14/2001 | EP1082419A2 Combination therapy using nucleic acids and conventional drugs |
| 03/14/2001 | EP1082416A2 Poly(adp-ribose)polymerase gene |
| 03/14/2001 | EP1082412A2 Transfected cells and methods for treating diabetes |
| 03/14/2001 | EP1082411A2 Method for preparation and in vivo administration of antigen presenting cell composition |
| 03/14/2001 | EP1082410A1 Human cd45+ and/or fibroblast + mesenchymal stem cells |
| 03/14/2001 | EP1082404A2 Multiply-substituted protease variant and amylase variant-containing cleaning compositions |
| 03/14/2001 | EP1082341A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 03/14/2001 | EP1082335A1 Novel secreted and membrane-associated proteins and uses therefor |
| 03/14/2001 | EP1082334A1 Alg-2lp, alg-2 like molecules and uses therefor |
| 03/14/2001 | EP1082141A1 Cd40 binding molecules and ctl peptides for treating tumors |
| 03/14/2001 | EP1082136A1 The cytokine family member, 2-19 |
| 03/14/2001 | EP1082134A2 Composition comprising tumor cells and extracts and method of using thereof |
| 03/14/2001 | EP1082126A1 Novel peptides |
| 03/14/2001 | EP1082071A2 Bioengineered flat sheet graft prostheses |
| 03/14/2001 | EP0987936A4 Fatty acid desaturases and mutant sequences thereof |
| 03/14/2001 | CN1287166A Separation, extracorporeal culture, preparation and application of human primitive mesenchymal stem cell population |
| 03/14/2001 | CN1063226C Method for detecting & screening bioactivity active constituent additive for cosmetics |
| 03/13/2001 | US6201169 Transgenic brassica plant; stable integration and under control of expression signals; produced by contacting exogenous dna with plant protoplast using polyethylene glycol treatment, electroporation, and/or heat shock |
| 03/13/2001 | US6201165 Drug screening by contacting isolated cardiomyocyte having calcineurin, calcium calmodulin dependent kinase iv or ii alpha, p38, or mkk6 transgene with compound; measuring physiological parameter; and comparing to control |
| 03/13/2001 | US6201111 Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors |
| 03/13/2001 | US6201106 Cytokine signal regulators |
| 03/13/2001 | US6200960 Inhibition of proliferation of cells |
| 03/13/2001 | US6200951 For detecting chitin, binding chitin, and treating fungal infections or for development of products useful for fungal infection therapy |
| 03/13/2001 | US6200811 For making human immunodeficiency virus resistant cells; gene therapy |
| 03/13/2001 | US6200808 Induction of embryogenesis from plant microspores |
| 03/13/2001 | US6200806 Primate embryonic stem cells |
| 03/13/2001 | US6200805 Human cell line cloned from cell which has been stably transformed by recombinant vector having reporter gene linked to human interleukin-4-repsonsive element |